Copy For Citation
Demir A., Cecen K., Karadag M. A., Kocaaslan R., Turkeri L.
SPRINGERPLUS, vol.3, 2014 (SCI-Expanded)
Article / Article
Science Citation Index Expanded (SCI-EXPANDED)
Metastatic prostate cancer, Treatment modality, Course, ANDROGEN-DEPRIVATION THERAPY, CARDIOVASCULAR COMPLICATIONS, HORMONAL-THERAPY, CASTRATION, BLOCKADE, TRIAL, MEN, BICALUTAMIDE, ORCHIECTOMY, MANAGEMENT
Acibadem Mehmet Ali Aydinlar University Affiliated:
The first-line management of metastatic prostate cancer is hormonal therapy. However, resistance to this treatment will emerge within an average of 24 months. Our purpose was to determine the course of metastatic prostate cancer under treatment.